Article

Navigating the commercialization of cell and gene therapies

This article was originally published on European Pharmaceutical Review (EPR) on May 19, 2025

Kevin Chinn, VP and Head of Cell and Gene Service Line at Cencora, talks about the hurdles to making cell and gene therapy a commercial success – and how to leap over them.

Read the article to explore the potential and major obstacles impacting cell and gene therapies in the pharmaceutical industry.

Pardot Form

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.

Related resources

Article

Harnessing AI and advanced analytics to revolutionize PV signal management

Learn more

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape

Learn more

Article

The growing case for AI to support pharmacovigilance: World Drug Safety Congress Americas key takeaways

Learn more